In January 2009, the United States escalated a long-running dispute with the European Union (EU) over its refusal to accept imports of U.S. poultry treated with certain pathogen reduction treatments (PRTs). PRTs are antimicrobial rinses that have been approved for use by the U.S. Department of Agriculture (USDA) in poultry production to reduce the amount of microbes on meat. Meat and poultry products processed with PRTs are judged safe by the United States and also by European food safety authorities. Nevertheless, the EU prohibits the use of PRTs and the importation of poultry treated with these substances. The EU generally opposes such chemical interventions and asserts that its own poultry producers follow much stricter production and processing rules that are more effective in reducing microbiological contamination than simply washing products at the end of the process. This dispute dates to 1997, when the EU first banned the use of PRTs on poultry, effectively shutting out virtually all imports from the United States since then. Such treatments are routinely used in U.S. chicken and turkey plants. The United States views the EU ban as a trade barrier that is not based on scientific evidence showing that such treatments are harmful. EU interests believe that stronger sanitary practices during production and processing are more appropriate for pathogen control than what they view as U.S. overreliance on PRTs. The United States has requested World Trade Organization (WTO) consultations with the EU on the matter, a prerequisite first step toward the establishment of a formal WTO dispute settlement panel. Although the WTO case has not moved forward, the U.S. poultry industry and the U.S. Trade Representative (USTR) continue to actively pursue the case. This issue has also been raised in ongoing trade negotiations between the United States and EU to establish a free trade area as part of the Transatlantic Trade and Investment Partnership (T-TIP). The United States is the second largest exporter of poultry meat (broiler and turkey) in the world, trailing only Brazil. Together these two countries account for nearly 70% of total broiler meat exports, by volume. The EU is the world's second-largest importer of poultry meat and accounts for about 8% (by volume) of all world broiler meat imports. In 2015, the EU imported an estimated 155,000 metric tonnes of fresh, chilled, or frozen poultry meat from outside the EU in 2015, which was valued at $370 million. According to USDA, virtually no U.S. poultry meat is being purchased for consumption in the EU. However, prior to 1997, when the EU began to prohibit U.S. poultry because of the PRT rule, the United States was a supplier of broiler and turkey meat to the 15 countries that then constituted the EU. As additional countries have joined the EU, the United States has likely lost markets in Europe. Some estimate that the combined effects of the ban and the growth of the EU market may have led to $200 million to $300 million in lost U.S. sales annually. The EU began to prohibit the use of PRTs for both domestic and imported poultry in 1997. Key language in the regulations reads, in part, "[f]ood business operators shall not use any substance other than potable water"—or, when otherwise permitted, "clean water—to remove surface contamination from products of animal origin," unless use of another substance has specifically been approved by the EU. In 2002, the United States asked the EU to approve the use of four PRTs on poultry destined for export there. These included chlorine dioxide, acidified sodium chlorate, trisodium phosphate, and peroxyacids. Each is approved for use in poultry processing by both USDA and the U.S. Food and Drug Administration (FDA). More specifically, after birds are slaughtered and the carcasses eviscerated, a USDA inspector examines them for fecal contamination or other problems. They then enter a final washing procedure, where the PRTs may be applied, either as a spray or wash on the processing line, or as an addition to the water used to lower the carcass temperature (the chiller tank). Federal regulations further specify PRT concentration levels and other usage requirements. Following the U.S. request for use of these four PRTs, several key European opinions on PRT use were issued. These opinions helped form the basis for the U.S. request to allow them. For example, the European Food Safety Authority (EFSA), in December 2005, adopted an opinion that use of the four PRTs under described conditions "does not present any risk to public health" but that "the use of antimicrobial solutions does not replace the need for good hygienic practices during processing of poultry carcasses, particularly during handling." A second EFSA opinion that month also pointed out that information on one of the substances, peroxyacids, indicated limited effectiveness, requiring that specific conditions of use should be defined. In April 2008, EFSA published another scientific opinion which found that "there are currently no published data to conclude in whatever way" that these substances, when applied on poultry carcasses, cause "acquired reduced susceptibility" (a buildup in resistance to the PRTs), or cause resistance to therapeutic antimicrobials. Around the same time, two other scientific committees under the auspices of the Health and Consumer Protection Directorate-General of the European Commission (EC) issued a joint opinion suggesting that there appeared to be low environmental risk associated with residues on carcasses, but that there was not enough data for it to make a comprehensive assessment, particularly with regard to post-processing environmental risk. In December 2008, the EU rejected the U.S. request of approval for use of four PRTs on poultry destined for export to the EU. This followed a U.S.-EU economic summit in May 2008, where the EC committed to proposed EU regulatory changes that would permit PRT-treated poultry meat to be imported or produced in EU member states. Changes to the EU's Food Hygiene Regulation were offered, in June 2008, to the Standing Committee on the Food Chain and Animal Health but were overwhelmingly rejected (316-0, with 29 abstentions). The same proposal was considered in December 2008, by the EU Agricultural and Fisheries Council, representing the agricultural ministers of the EU member states. They too rejected it by the same vote margin. In response to the EC's explicit prohibition of these four PRTs and the importation of poultry treated with such substances, the United States requested WTO consultations in January 2009. The outgoing Bush Administration expressed its frustration with the EU's decision not to allow U.S. poultry processed using these PRTs, given what it characterized as several favorable European scientific opinions that PRTs pose no risk to human health. The Bush Administration expressed concern that even the rejected changes represented a "heavily conditioned" proposal, including requirements for labeling, a limitation on PRT use to carcasses, not parts, and a limitation to use of a single PRT (not a combination of them) to be followed by potable water rinses. USTR concluded that this issue could not be resolved through further negotiation and initiated its request to establish a WTO panel to determine whether the EU is acting consistently with its WTO obligations. The U.S. poultry industry supported the WTO filing by the USTR and encouraged the Obama Administration to continue to pursue the case. The United States and the EU continued to hold consultations starting again in February 2009. The U.S. request for WTO consultations on the poultry matter was filed on January 16, 2009. It states that the EU ban on PRTs in poultry processing violates the EU's WTO obligations under both the Agreement on the Application of Sanitary and Phytosanitary (SPS) Measures and the Agreement on Technical Barriers to Trade (TBTs). (For more information on these two agreements, see text box on next page.) Specifically, the U.S. filing states that the ban by the EU on PRTs for poultry appears to violate the following WTO obligations: Article 2.2 of the SPS agreement, which permits only those measures necessary to protect human, animal, and plant life or health and that are based on scientific principles; SPS Article 5, which governs risk assessment and determination of the appropriate level of SPS protection, with the objective of minimizing trade impacts; SPS Article 8, on control, inspection, and approval procedures, which are aimed at treating imports no less favorably than domestic products; and Article 2 of the TBT Agreement, which is intended to assure that TBT measures do not discriminate against imports or create unjustified barriers to trade. In October 2009, despite initial consultations between the United States and the EU, the USTR asked the WTO to establish a dispute settlement panel regarding the EU's restrictions on imports of U.S. poultry. The United States has asked the panel to review whether the EU's ban on the import and marketing of poultry meat and poultry meat products processed with PRTs violates the EU's WTO obligations. USTR and the U.S. poultry industry remain actively engaged in this case. A panel was established in November 2009, but this case has not moved forward. Formal WTO cases can take many years to be resolved to the satisfaction of either party. A case in point is the long-running U.S.-EU dispute over the use of hormones in beef, which the EU prohibits and which has kept beef from the United States, where they are used, out of the EU market for many years. Several WTO dispute panel rulings concluded that the EU hormone ban is scientifically unjustified and inconsistent with WTO rules, and the United States imposed WTO-approved retaliatory tariffs on some EU imports. However, the EU continued to enforce its hormone ban. Decades later, although the United States and the EU signed a memorandum of understanding (MOU) in 2009 in an attempt to eventually resolve this long-standing dispute, this issue is far from fully resolved. Meanwhile, as EU officials have pointed out, the United States is permitted to, and does, export hormone-free beef to the EU; likewise, U.S. poultry meat not treated with PRTs likely would be accepted. The United States and the EU maintain widely divergent views not only on the poultry issue but on some aspects of their basic approach to food safety regulation, which further complicates this issue. The EU generally employs a more "precautionary approach" and also enforces restrictions on the use of both antibiotics and hormones in animal production, among other types of processes and chemicals for use in food production. A widely held European view appears to be that the U.S. use of these treatments compensates for poor sanitary standards earlier in the production process. European poultry producers assert that they follow much stricter production and processing rules that are more successful in reducing microbiological contamination than simply washing products at the end of the process. In its June 2008 resolution, the European Parliament claimed that the European industry had made "considerable investments in accordance with Community legislation, with a view to reducing pathogen contamination by implementing a total food chain approach." The resolution also argued, among other things, that to allow the use of PRTs given the lack of evidence supporting their safety "is out of step with both the European public's food safety and hygiene expectations and the demand for production models—both within and outside Europe—which ensure that high hygiene standards are maintained throughout the production and distribution process," and would likely "undermine European consumer confidence in foodstuffs sold within the European Union, which remains fragile following the food safety problems that have arisen within the Union over recent years." Nevertheless, a 2012 scientific opinion by European Food Safety Authority (EFSA) recommends changes to the EU's own meat inspection procedures, criticizing its efforts for detecting and controlling Campylobacter and Salmonella in chicken meat. Regarding chemical intervention, the opinion further states that "chemical substances in poultry are unlikely to pose an immediate or acute health risk for consumers." This followed the release of 2011 guidelines issued by the international food safety organization Codex Alimentarius Commission (Codex) for the control of Campylobacter and Salmonella in chicken meat. These Codex guidelines cover, among other types of production controls, the use of certain hazard-based control measures, including acidified sodium chlorite and trisodium phosphate, among other antimicrobial rinses and oxidants. Some believe the Codex guidelines might effectively resolve concerns about the use of these substances in poultry processing. Furthermore, starting in 2013, the EU lifted its ban on the use of lactic acid on beef PRTs on beef carcasses, half-carcasses, and beef quarters in the slaughterhouse. Many in the United States considered this action to be a "major victory for science-based food processing." To date, the U.S. and EU have not been able to reach agreement on a number of issues related to veterinary equivalency, and the EU continues to maintain measures that prohibit the use of any substance other than water to remove contamination from animal products unless the substance has been approved by the European Commission, which has rejected USDA's applications to the EU's health agencies requesting approval to use certain poultry treatments. The U.S. is seeking approval of four PRTs: peroxyacetic acid, chlorine dioxide, acidified sodium chlorite, and trisodium. This issue also continues to be raised in trade negotiations between the United States and EU to establish a free trade area as part of the Transatlantic Trade and Investment Partnership (T-TIP). The U.S. poultry industry has indicated that it is unlikely to support a T-TIP agreement that does not provide for better access to the EU of U.S poultry products.

Summary: In January 2009, the United States escalated a long-running dispute with the European Union (EU) over its refusal to accept imports of U.S. poultry treated with certain pathogen reduction treatments (PRTs) by requesting World Trade Organization (WTO) consultations with the EU on the matter, a prerequisite first step toward the establishment of a formal WTO dispute settlement panel. This dispute dates back to 1997, when the EU first banned the use of PRTs on poultry, effectively shutting out virtually all imports from the United States since then. This WTO case has not moved forward. PRTs are antimicrobial rinses—including chlorine dioxide, acidified sodium chlorite, trisodium phosphate, and peroxyacids, among others—that have been approved by the U.S. Department of Agriculture (USDA) for use in poultry processing to reduce the amount of microbes on meat. Meat and poultry products processed with PRTs are judged safe by the United States and also by European food safety authorities. Nevertheless, the EU prohibits the use of PRTs and the importation of poultry treated with these substances. The EU generally opposes such chemical interventions and believes that stronger sanitary practices during production and processing are more appropriate for pathogen control than what it views as U.S. overreliance on PRTs. As PRTs are widely used in U.S. poultry processing, the EU's ban on their use effectively prohibits U.S. poultry meat from entering EU countries. Although the United States is the second largest global exporter of poultry (broiler and turkey) meat, virtually no U.S. poultry meat is being purchased for consumption in the EU, according to USDA. As the EU is a major importer of poultry products, some estimate that the combined effects of the ban and the growth of the EU market may have led to $200 million to $300 million in lost U.S. sales annually. To date, the United States and EU have not been able to reach agreement on a number of issues related to veterinary equivalency, and the EU continues to maintain measures that prohibit the use of any substance other than water to remove contamination from animal products unless the substance has been approved by the European Commission, which has rejected USDA's applications to the EU's health agencies requesting approval to use certain poultry treatments. The United States is seeking approval of four PRTs: peroxyacetic acid, chlorine dioxide, acidified sodium chlorite, and trisodium. The U.S. poultry industry and the U.S. Trade Representative (USTR) remain actively engaged in this case. This issue also continues to be raised in ongoing trade negotiations between the United States and EU to establish a free trade area as part of the Transatlantic Trade and Investment Partnership (T-TIP). The U.S. poultry industry has indicated that it is unlikely to support a T-TIP agreement that does not provide for better access to the EU of U.S. poultry products.